The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMW 2019 | When is allogeneic transplant the right answer for MM?
Gösta Gahrton
• 15 Sep 2019
Gösta Gahrton, MD, of Karolinska University Hospital, Stockholm, Sweden, discusses when is allogeneic transplant the right answer for patients with myeloma. Recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
